Serum biomarkers of inflammation and vascular damage upon SARS-Cov-2 mRNA vaccine in patients with thymic epithelial tumors

Abstract

Objectives Thymic epithelial tumors (TET) patients are at high risk of autoimmune and hypoimmune complications. Limited evidence is available on the potential risk of immune-related and inflammatory reactions induced by SARS-Cov-2 vaccine in this patient population. Methods In order to identify subjects at higher risk for vaccine complications, we prospectively evaluated a panel of serum biomarkers related to inflammation (TNF-α, IL-1β, −6, −10, −12, and −17A, IFN-α, β and γ, MPO, MMP-9), and vascular damage (E- and P-selectin, VEGF-A, P-ANCA and MCP-1) in 44 TET patients and in 30 healthy controls along the whole SARS-Cov-2 vaccine cycle. Results About 50 % of subjects (either TET and controls) showed an increase of serum biochemical markers of inflammation and endothelial damage with a large heterogeneity of values. Such increase appeared early, after the first dose in control subjects and later, after the second dose in TET patients (in which we observed mainly an increase of inflammatory biomarkers). The values normalized after about 3 months and did not increase after the third, booster dose. No autoimmune or vascular complications were observed in the study subjects and no difference was observed in terms of vaccine response among subjects showing serum biomarkers increase and those who experienced no changes. Conclusions Our data highlight the relevance of Sars-Cov-2 vaccine in TET patients, as it resulted safe and prevented severe COVID-19. However, further studies are awaited to explore the mechanisms and the potential consequences of the observed increase of serum inflammatory and vascular damage biomarkers.

COVID-19 vaccination-related tinnitus is associated with pre-vaccination metabolic disorders

“…In addition to direct interaction with the brain cells, COVID-19 vaccines can cause rapid systemic inflammatory responses secondary to reactogenicity of the vaccines ( Heo et al, 2022 ). COVID-19 vaccines have also been associated with endothelial dysfunction and vascular inflammation ( Terentes-Printzios et al, 2022 ; Yoshimoto et al, 2023 ; Cernera et al, 2024 ), including brain blood vessels ( Ariyoshi et al, 2023 ). These systemic and vascular inflammation could disrupt blood-brain barrier and other brain function, and potentially lead to tinnitus and other mental health issues (G. Yang, Parkhurst, Hayes and Gan, 2013 ).…”